FDA LISTING INC: EXPERIENCED ADVISORS FOR FULL-SERVICE FDA REGISTRATION & COMPLIANCE
+1 212 444 8202
Topical acne products are OTC drug products intended to reduce acne blemishes, pimples, blackheads, and whiteheads. FDA Monograph M006 covers certain topical acne products, including face washes, cleansers, creams, gels, lotions, spot treatments, pads, swabs, and similar topical dosage forms.
For brand owners, importers, private-label companies, and manufacturers, key compliance considerations include the active ingredient and concentration, intended use, dosage form, ingredient combinations, Drug Facts labeling, required warnings, directions for use, and FDA drug establishment registration and drug-listing requirements.
FDA Monograph M006 may apply to acne face washes, cleansers, creams, gels, lotions, serums, spot treatments, pads, swabs, and similar topical products marketed to treat acne blemishes, pimples, blackheads, or whiteheads. The product format alone does not determine whether a product fits the monograph. Also review the active ingredient, concentration, intended use, dosage form, directions for use, warning statements, and labeling claims. A product’s claims should match the applicable active ingredient conditions and the finished formulation.
Some OTC acne products are marketed under an approved new drug application rather than OTC Monograph M006. For example, adapalene 0.1% products are not M006 monograph products and should be evaluated under their applicable regulatory pathway.
| Active Ingredient | Concentration Range | Common Product Terms |
|---|---|---|
| Benzoyl peroxide | 2.5% to 10% | Benzoyl peroxide face wash, acne cleanser, acne spot treatment |
| Salicylic acid | 0.5% to 2% | Salicylic acid acne wash, acne toner, acne treatment gel |
| Sulfur | 3% to 10% | Sulfur acne treatment, sulfur mask, acne spot treatment |
| Sulfur with resorcinol or resorcinol monoacetate | 3% to 8% sulfur combined with 2% resorcinol or 3% resorcinol monoacetate | Combination acne treatment, sulfur-resorcinol acne cream or lotion |
Acne product claims should match the active ingredient, concentration, intended use, and finished dosage form. Products covered by M006 may be marketed to help treat acne blemishes, acne pimples, blackheads, and whiteheads.
A product should not use broader claims for treating hormonal acne, cystic acne, acne scars, inflammation, bacterial infections, or other skin conditions unless those claims are supported through an appropriate regulatory pathway. Claims on packaging, e-commerce listings, retailer descriptions, websites, social media, and advertising should remain consistent with the Drug Facts panel.
The Drug Facts panel should identify each active ingredient and its concentration, together with the corresponding purpose. The product name, front-label claims, and terms such as “acne treatment,” “acne medication,” “blemish control,” or “pimple treatment” should match the product’s active ingredient and permitted intended use.
If an acne product contains more than one active ingredient, review the formulation and labeling for applicable combination conditions. Do not assume that separately permitted acne active ingredients can be combined in any concentration, dosage form, or claim combination.
Topical acne products generally require product-specific warnings and directions. Depending on the active ingredient and finished product, labeling may address skin irritation, dryness, peeling, redness, swelling, rash, burning, itching, or other reactions.
Benzoyl peroxide and salicylic acid acne products should include applicable hypersensitivity and skin-reaction warnings. Before first use, consumers should apply a small amount to one or two small affected areas for three days. If no discomfort occurs, consumers may use the product as directed. Labeling should also instruct consumers to stop use and seek medical help if they experience swelling of the eyes, face, lips, or tongue; throat tightness; difficulty breathing; or faintness.
Directions should match the active ingredient, product type, frequency of use, and applicable age group. For example, directions for a leave-on acne treatment may differ from a face wash or cleanser. Benzoyl peroxide products may also require warnings regarding bleaching of hair or dyed fabrics.
Acne products should include appropriate Drug Facts information, including active ingredients, purpose, uses, warnings, directions, and inactive ingredients. The Drug Facts panel should correspond to the finished product that is commercially distributed.
Review product names, “acne medication” statements, blemish-treatment claims, website content, retailer descriptions, and advertising for consistency with the Drug Facts panel. Claims on e-commerce listings, social media, and other marketing materials should not expand the product’s permitted intended use.
This page provides a simplified overview of FDA OTC Monograph M006. It does not include every active ingredient, concentration range, permitted combination, dosage-form requirement, testing requirement, labeling detail, warning, direction, or FDA administrative order that may apply to a specific acne product.
For complete and current requirements, including active-ingredient conditions and administrative orders applicable to OTC topical acne drug products, review the related official FDA monograph resource.
We assist with:
_______ Related Services _______
_______ Related Services _______